Diabetes medications linked to increased risk of amputation Medha Baranwal Baranwal19 Nov 2018 7:28 PM ISTType 2 diabetes (T2D) patients treated with sodium-glucose cotransporter 2 (SGLT2) inhibitors have an increased risk of lower-limb amputation and...
New Therapies for risk reduction in Diabetes with CVD: ACC guidance Medha Baranwal Baranwal29 Nov 2018 7:00 PM ISTThe American College of Cardiology has released new guidance on novel therapies for reduction of cardiovascular (CV) risk in patients with...
GLP-1 receptor agonist not associated with diabetic retinopathy Medha Baranwal Baranwal1 Jan 2019 7:20 PM ISTUSA: An analysis of the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database has revealed that glucagon-like peptide 1...
Dapagliflozin reduces hospitalisation rate and death risk in heart failure: DECLARE Trial Medha Baranwal Baranwal21 March 2019 7:25 PM ISTDELHI: Diabetes drug dapagliflozin offers cardiovascular benefits that extend across a wide spectrum of patients with heart failure, and also reduces...
What is the optimum medical therapy for diabetes management: Status 2019 Medha Baranwal Baranwal18 April 2019 7:03 PM ISTDiabetes in 2019 has been understood as a multi-organ and a multi-specialty disease. It affects the eyes, nerves, kidney, vessels, brain, and heart...
FDA approves combination drug for better blood sugar control in Diabetes Deepanjana Sarkar10 May 2019 7:05 PM ISTFDA approves combination drug for better blood sugar control in Diabetes.The U.S Food and Administration has approved a combination drug formula...
ADA 2019 Highlights: Primary And secondary Prevention Outcomes From CREDENCE Dr. Kartikeya16 Jun 2019 7:02 PM ISTThe CREDENCE Trial outcomes came as a big win for patients with Type 2 Diabetes Mellitus(T2DM) and Chronic Kidney Disease (CKD), considering the high...
SGLT2 inhibitors reduce blood sugar fluctuations in diabetes when added to Sulfonylureas Deepanjana Sarkar26 July 2019 7:28 PM ISTSodium-glucose cotransporter 2 (SGLT2) inhibitors added to sulfonylureas therapy for Type 2 Diabetes patients may reduce blood sugar fluctuations and...
Modify risk rather than merely relying on blood sugar lowering drugs in diabetes: DECLARE-TIMI Medha Baranwal Baranwal27 Sept 2019 7:28 PM ISTModify risk rather than merely relying on blood sugar lowering drugs in diabetes, finds DECLARE-TIMI Phase IIIB trial.Researchers, based on their...
Some diabetes drugs can cut dementia risk, finds study Medha Baranwal Baranwal22 Oct 2019 8:10 PM ISTDenmark: The use of certain diabetes medication -- metformin, DPP4 inhibitors, GLP1 analogs and SGLT2 inhibitors -- cuts dementia risk in people with...
Top Cardiology News: 2019 Medha Baranwal Baranwal29 Dec 2019 8:28 PM ISTThe year 2019 witnessed another active year for research and clinical advances in the field of cardiology. New drugs, devices, diagnoses, prognoses...
SGLT2 inhibitors might protect diabetes patients from gout Medha Baranwal Baranwal14 Jan 2020 11:39 AM ISTUSA: Hyperuricemia, known to cause gout, is common in patients with type 2 diabetes (T2D). Now, a recent study has found that prescribing a...
